MelCure SA: Clinical Trials

1 trial sponsored by MelCure SA, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 11Terminated 1

Follow MelCure SA: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proof of Concept Study With an Endothelin Receptor B Inhibitor (BQ-788) for Human Melanoma
Endothelin Receptor B inhibitor BQ788, PBS - Melanoma
Early Phase 1TerminatedMelCure SA52011-05-012015-05-20

Conditions studied

Melanoma (1)

Results publications

PMID 26330458